B3. Operating expenses
Operating expenses by function and type of cost
SEKm |
2018 |
2017 |
2016 |
IS Cost of goods sold |
–85,058 |
–76,899 |
–72,438 |
IS Sales, general and administration |
–20,570 |
–19,130 |
–16,965 |
IS Amortization of acquisition-related intangible assets |
–732 |
–560 |
–159 |
IS TB3:1 Items affecting comparability |
–1,444 |
–940 |
–2,825 |
Total |
–107,804 |
–97,529 |
–92,387 |
Refer also to the chapter Description of costs.
SEKm |
Note |
2018 |
2017 |
2016 |
||||
|
||||||||
TB3:2 Other income |
|
897 |
1,045 |
970 |
||||
Change in inventory of finished products and products in progress1) |
|
196 |
172 |
–82 |
||||
Raw materials and consumables1) |
|
–43,771 |
–38,191 |
–36,442 |
||||
Personnel costs1) |
–22,021 |
–20,142 |
–17,983 |
|||||
TB3:3 Other operating expenses1) |
|
–36,412 |
–34,444 |
–33,242 |
||||
Amortization of intangible assets1) |
–1,049 |
–853 |
–380 |
|||||
Depreciation of property, plant and equipment1) |
–5,126 |
–4,871 |
–4,764 |
|||||
Impairment of intangible assets1) |
–105 |
–132 |
–137 |
|||||
Impairment of property, plant and equipment1) |
–428 |
–254 |
–420 |
|||||
Share in profits of associates1) |
|
–278 |
– |
– |
||||
Revaluation of previously owned shares in associates1) |
225 |
72 |
– |
|||||
Gain on divestment1)2) |
|
68 |
69 |
93 |
||||
Total |
|
–107,804 |
–97,529 |
–92,387 |
TB3:1 Items affecting comparability
SEKm |
2018 |
2017 |
2016 |
Impairment of inventory of finished products and products in progress |
–61 |
–4 |
–156 |
Raw materials and consumables |
– |
– |
–102 |
Personnel costs |
–700 |
–69 |
–76 |
Other operating expenses |
–183 |
–620 |
–1,948 |
Amortization of intangible assets |
– |
–2 |
–43 |
Depreciation of property, plant and equipment |
– |
– |
–36 |
Impairment of intangible assets |
–105 |
–132 |
–137 |
Impairment of property, plant and equipment |
–410 |
–254 |
–420 |
Impairment losses recognized in associates |
–278 |
– |
– |
Revaluation of previously owned shares in associates |
225 |
72 |
– |
Gain on divestment |
68 |
69 |
93 |
Total |
–1,444 |
–940 |
–2,825 |
SEKm |
2018 |
Costs for restructuring measures at production facilities of Professional Hygiene and Consumer Tissue |
–1,222 |
Impairment in the associate Asaleo Care Ltd. |
–278 |
Increase in participations in joint venture in Latin America |
165 |
Dissolution of reserve for foreign tax |
288 |
Restructuring costs relating to the Group-wide savings program |
–131 |
Other |
–266 |
Total |
–1,444 |
SEKm |
2017 |
Costs of split of SCA Group into two listed companies |
–550 |
Integration and transaction costs related to the acquisition of BSN medical and inventory valuation arising from acquisition balance |
–435 |
Closure of tissue production plant in the US |
–255 |
Restructuring costs for the closure of the tissue machine in the UK |
–75 |
Reversal of provisions for competition case in Poland |
265 |
Other |
110 |
Total |
–940 |
SEKm |
2016 |
Costs for legal disputes |
–1,086 |
Costs for closure of tissue production plants in Spain and France |
–757 |
Costs for closure of operation in India |
–374 |
Costs for closure of baby diaper operation in Mexico |
–174 |
Costs in conjunction with the acquisition of Wausau Paper Corp. |
–204 |
Transaction costs BSN medical |
–143 |
Other |
–87 |
Total |
–2,825 |
SEKm |
2018 |
2017 |
2016 |
Sales not included in core operations |
897 |
1,045 |
970 |
Total |
897 |
1,045 |
970 |
Other revenue includes rental revenue, which is recognized in the period covered by the rental contract, royalties and similar items, which are recognized in accordance with the implied financial effect of the contract.
SEKm |
2018 |
2017 |
2016 |
||
|
|||||
Transport expenses |
–8,290 |
–7,425 |
–7,120 |
||
Energy costs1) |
–4,775 |
–4,498 |
–4,448 |
||
Purchased finished goods for resale |
–5,144 |
–5,053 |
–3,739 |
||
Marketing costs |
–6,031 |
–5,777 |
–5,504 |
||
Repairs and maintenance |
–2,546 |
–2,436 |
–2,537 |
||
IT, telephony and lease of premises |
–1,633 |
–1,380 |
–1,445 |
||
Other operating expenses, production |
–3,919 |
–3,671 |
–3,291 |
||
Other operating expenses, distribution, sales and administration |
–3,674 |
–3,644 |
–3,090 |
||
Other |
–400 |
–560 |
–2,068 |
||
Total |
–36,412 |
–34,444 |
–33,242 |
Other disclosures
Exchange rate effects had a negative impact of SEK –189m (–10; –97) on operating profit. Government grants received reduced operating expenses by SEK 55m (65; 41). Costs for research and development amounted to SEK –1,320m (–1,239; –1,211) during the period.